Yarrow Bioscience stock: Three November investor events ahead

Yarrow Bioscience will take part in three investor conferences this month, giving investors several scheduled opportunities to hear from the clinical-stage biotechnology company. The announcement was published on November 2, 2026, by Morningstar, which reproduced the Business Wire release.

Three healthcare meetings on the calendar

Yarrow executives are scheduled for the Guggenheim Securities 3rd Annual Healthcare Innovation Conference in Boston on Monday, November 9. The program includes a fireside chat at 1:30 p.m. Eastern Time and individual investor meetings.

The company will also hold individual investor meetings at the Stifel Healthcare Conference in New York on Tuesday, November 10. The schedule then moves to London for individual meetings at the Jefferies Global Healthcare Conference on November 18 and 19.

Webcast gives investors a nearer catalyst

The Guggenheim fireside chat will be webcast through the Investors & News section of Yarrow's website. The replay is expected to remain available for 90 days, giving investors a further opportunity to review management's presentation.

The events are an investor-relations milestone rather than a clinical readout. Yarrow is developing YB-101, an anti-thyroid stimulating hormone receptor monoclonal antibody intended to address the central mechanism of Graves' disease and thyroid eye disease. Future investor attention is likely to remain focused on the development path and the company's ability to advance its pipeline.

Yarrow Bioscience stock is listed on Nasdaq under the ticker YARW. The company is based in New Haven, Connecticut, and describes itself as a clinical-stage biotechnology company focused on therapies for autoimmune thyroid diseases.

Broader market conditions can influence the biotechnology sector alongside company-specific development news; see the S&P 500 market overview.

More news and analyses on Yarrow Bioscience stock.